Image

SG2501 Safety Study in Subjects With Relapsed or Refractory Hematological Malignancies and Lymphoma.

Study on SG2501 safety for blood cancers and lymphoma patients.

Recruiting
18 years and older
All
Phase 1

This study is testing a new drug called SG2501 for people with blood cancers like lymphoma that have come back or don't respond to treatment. It's a phase Ia/Ib study, which means it's one of the first tests in humans to check if the drug is safe and how it works in the body. The study will occur in different places and will involve two phases to find the best dose.

In phase Ia, small groups will receive increasing doses to find the highest dose that doesn't cause bad side effects. Then, in phase Ib, more participants will get the drug at this dose to see if it's effective.

  • The study is for adults 18 and older with specific types of blood cancer.
  • Participants will have regular check-ups and tests to monitor their health.
  • Participants must agree to use contraception and avoid pregnancy during the study.

This study is important for developing new treatments for cancer, but it also requires commitment and frequent visits to the clinic. Make sure you understand the risks and benefits before deciding to participate.

Study details
    Hematological Malignancy
    Lymphoma

NCT05293912

Hangzhou Sumgen Biotech Co., Ltd.

13 December 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.